Caesarstone Reports Fourth Quarter and Full Year 2025 Financial Results
- Fourth Quarter Revenue of
- Implementation of Strategic Measures Expected to Bring Total Annualized Savings to Approximately
- Reiterates Expectation to Deliver Positive Adjusted EBITDA in the Third Quarter of 2026 -
MP MENASHE,
Manufacturing Facility Network and Cost Optimization Update
As previously announced, on
In connection with the facility closure, the Company incurred non-cash impairment expenses of
The Company incurred cash costs of
Once fully implemented the Company expects to realize annualized cash savings of approximately
The Company also continues to make progress in its efforts to monetize its previously closed
Beyond the facility closures, the Company’s restructuring plan continues to focus on additional actions that can be taken to improve future profitability and cash flow and help the Company to invest in its brand, innovation and porcelain. In addition, the Company believes these actions will help to achieve its goal to return to profitability during the third quarter of 2026.
Fourth Quarter 2025 Results
Revenue in the fourth quarter of 2025 was
Gross margin in the fourth quarter of 2025 was 15.5% compared to 19.4% in the prior year quarter. Excluding one-time expenses mainly related to the closure of the Bar-Lev facility, adjusted gross margin for the quarter was 18.0% compared to 19.7% in the prior year quarter. The difference in adjusted gross margin was primarily due to lower fixed cost absorption resulting from reduced production and sales volumes and the impact of recent tariffs which were not covered in full by the Company’s pricing actions implemented in the beginning of the quarter, partially offset by benefits from an improved production footprint.
Operating expenses in the fourth quarter of 2025 were
Operating loss in the fourth quarter of 2025 was
Adjusted EBITDA in the fourth quarter of 2025, which excludes expenses for non-cash share-based compensation, legal settlements and loss contingencies, restructuring charges, impairment expenses and other non-recurring items, was a loss of
Finance expenses in the fourth quarter of 2025 were
Net loss attributable to controlling interest for the fourth quarter of 2025 was
Full Year 2025 Results
Revenue in 2025 was
Gross margin in 2025 was 18.4% compared to 21.8% in 2024. Excluding one time expenses mainly related to the closure of the Bar-Lev plant, adjusted gross margin for the year was 19.0% compared to 22.1% in the prior year. The difference in gross margin was primarily due to lower volumes and production, which resulted in lower fixed cost absorption, partially offset by benefits from an improved production footprint.
Operating expenses in 2025 were
Operating loss in 2025 was
Adjusted EBITDA in 2025, which excludes non-cash impairment and restructuring charges, expenses for share-based compensation, legal settlements and loss contingencies and restructuring and impairment expenses and non-recurring items, was a loss of
Finance expenses in 2025 were
Net loss attributable to controlling interest in 2025 was
Balance Sheet & Liquidity
As of
The Company continues to monitor the impact of existing and proposed
In addition to these tariffs, on
Legal Proceedings Update
As of
In the
In
If there is a change in the assessment for the outcome of the claims or the insurance coverage limits through the course of the trial processes, such changes could have a material and adverse impact on our business, financial position, results of operations and cash flows. Additional information related to legal proceedings can be found in the Company’s Annual Report on form 20-F for the year ended
Closing Comment
"We enter 2026 with a significantly more flexible and efficient operational structure. We expect our improvements to support our return to positive adjusted EBITDA in the third quarter of 2026, positioning
About
Since it pioneered quartz countertops over thirty years ago, the brand has expanded into porcelain and natural stone and is on the ground in more than 50 countries worldwide while enhancing customer experience through the expansion of groundbreaking digital platforms & services. More information on
The Company has filed its annual report on Form 20-F for the year ended
Non-GAAP Financial Measures
The non-GAAP measures presented by the Company should be considered in addition to, and not as a substitute for, comparable GAAP measures. Reconciliations of GAAP gross profit to Adjusted gross profit, GAAP net income (loss) to Adjusted net income (loss) and net income (loss) to Adjusted EBITDA are provided in the schedules to this release. To calculate revenues growth rates that exclude the impact of changes in foreign currency exchange rates, the Company converts actual reported results from local currency to
Forward-Looking Statements
Information provided in this press release may contain statements relating to current expectations, estimates, forecasts and projections about future events that are "forward-looking statements" within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “goals," “intend,” “seek,” “anticipate,” “believe,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include statements regarding the Company’s goals and plans, intentions, expectations, assumptions, goals and beliefs regarding the Company’s business. Actual results may differ materially from those projections and estimates due to various risks and uncertainties, both known or unknown. These factors include, but are not limited to: the effects of the global and regional economy and geo-politics on the Company’s business and operations including the length, duration and impact of the war in
|
Condensed consolidated balance sheets |
||||||||
| As of | ||||||||
|
|
|
|
||||||
| (Audited) | (Audited) | |||||||
| ASSETS | ||||||||
| CURRENT ASSETS: | ||||||||
| Cash and cash equivalents and short-term bank deposits |
$ |
59,920 |
|
$ |
106,336 |
|
||
| Trade receivables, net |
|
48,292 |
|
|
46,880 |
|
||
| Other accounts receivable and prepaid expenses |
|
50,601 |
|
|
82,651 |
|
||
| Inventories |
|
94,275 |
|
|
112,609 |
|
||
| Total current assets |
|
253,088 |
|
|
348,476 |
|
||
| LONG-TERM ASSETS: | ||||||||
| Severance pay fund |
|
1,245 |
|
|
1,526 |
|
||
| Deferred tax assets, net |
|
4,010 |
|
|
2,910 |
|
||
| Long-term deposits and prepaid expenses |
|
5,179 |
|
|
4,750 |
|
||
| Operating lease right-of-use assets |
|
104,774 |
|
|
115,392 |
|
||
| Property, plant and equipment, net (*) |
|
30,146 |
|
|
75,724 |
|
||
| Intangible assets, net |
|
- |
|
|
263 |
|
||
| Total long-term assets |
|
145,354 |
|
|
200,565 |
|
||
| Total assets |
$ |
398,442 |
|
$ |
549,041 |
|
||
| LIABILITIES AND EQUITY | ||||||||
| CURRENT LIABILITIES: | ||||||||
| Short-term bank credit and other loans |
$ |
2,853 |
|
$ |
4,555 |
|
||
| Trade payables |
|
37,779 |
|
|
52,838 |
|
||
| Related parties |
|
247 |
|
|
206 |
|
||
| Short term legal settlements and loss contingencies |
|
38,577 |
|
|
42,706 |
|
||
| Accrued expenses and other liabilities |
|
58,718 |
|
|
51,383 |
|
||
| Total current liabilities |
|
138,174 |
|
|
151,688 |
|
||
| LONG-TERM LIABILITIES: | ||||||||
| Long-term bank and other loans |
|
- |
|
|
444 |
|
||
| Legal settlements and loss contingencies long-term and other liabilities |
|
8,735 |
|
|
9,492 |
|
||
| Deferred tax liabilities, net |
|
2,168 |
|
|
2,439 |
|
||
| Long-term lease liabilities |
|
106,377 |
|
|
107,313 |
|
||
| Accrued severance pay |
|
2,886 |
|
|
2,978 |
|
||
| Long-term warranty provision |
|
889 |
|
|
902 |
|
||
| Total long-term liabilities |
|
121,055 |
|
|
123,568 |
|
||
| REDEEMABLE NON-CONTROLLING INTEREST |
|
- |
|
|
2,200 |
|
||
| EQUITY: | ||||||||
| Ordinary shares |
|
371 |
|
|
371 |
|
||
|
|
|
(39,430 |
) |
|
(39,430 |
) |
||
| Additional paid-in capital |
|
167,700 |
|
|
166,500 |
|
||
| Capital fund related to non-controlling interest |
|
(5,587 |
) |
|
(5,587 |
) |
||
| Accumulated other comprehensive income (loss), net |
|
(10,874 |
) |
|
(14,870 |
) |
||
| Retained earnings |
|
27,033 |
|
|
164,601 |
|
||
| Total equity |
|
139,213 |
|
|
271,585 |
|
||
| Total liabilities and equity |
$ |
398,442 |
|
$ |
549,041 |
|
||
|
|
|||||||||||||||||
|
|
|||||||||||||||||
|
Three months ended |
Twelve months |
||||||||||||||||
|
|
2025 |
2024 |
2025 |
2024 |
|||||||||||||
| (Unaudited) | (Audited) | ||||||||||||||||
| Revenues |
$ |
94,435 |
|
$ |
97,863 |
|
$ |
397,228 |
|
$ |
443,221 |
|
|||||
| Cost of revenues |
|
79,827 |
|
|
78,875 |
|
|
323,948 |
|
|
346,546 |
|
|||||
| Gross profit |
|
14,608 |
|
|
18,988 |
|
|
73,280 |
|
|
96,675 |
|
|||||
| Operating expenses: | |||||||||||||||||
| Research and development |
|
1,361 |
|
|
1,446 |
|
|
5,674 |
|
|
4,950 |
|
|||||
| Sales and Marketing |
|
20,290 |
|
|
20,191 |
|
|
79,521 |
|
|
86,239 |
|
|||||
| General and administrative |
|
10,381 |
|
|
10,915 |
|
|
39,486 |
|
|
39,123 |
|
|||||
| Restructuring expenses (*) |
|
3,050 |
|
|
7,763 |
|
|
3,096 |
|
|
1,007 |
|
|||||
| Impairment expenses (**) |
|
45,657 |
|
|
- |
|
|
45,657 |
|
|
- |
|
|||||
| Legal settlements and loss contingencies, net |
|
16,177 |
|
|
1,629 |
|
|
25,555 |
|
|
7,242 |
|
|||||
| Total operating expenses |
|
96,916 |
|
|
41,944 |
|
|
198,989 |
|
|
138,561 |
|
|||||
| Operating loss |
|
(82,308 |
) |
|
(22,956 |
) |
|
(125,709 |
) |
|
(41,886 |
) |
|||||
| Finance expenses, net |
|
2,747 |
|
|
2,860 |
|
|
7,766 |
|
|
9 |
|
|||||
| Loss before taxes |
|
(85,055 |
) |
|
(25,816 |
) |
|
(133,475 |
) |
|
(41,895 |
) |
|||||
| Tax expenses (income), net |
|
2,881 |
|
|
(1,361 |
) |
|
4,284 |
|
|
1,081 |
|
|||||
| Net loss |
$ |
(87,936 |
) |
$ |
(24,455 |
) |
$ |
(137,759 |
) |
$ |
(42,976 |
) |
|||||
| Net loss attributable to non-controlling interest |
|
- |
|
|
111 |
|
|
292 |
|
|
144 |
|
|||||
| Net loss attributable to controlling interest |
$ |
(87,936 |
) |
$ |
(24,344 |
) |
$ |
(137,467 |
) |
$ |
(42,832 |
) |
|||||
| Basic net loss per ordinary share (***) |
$ |
(2.55 |
) |
$ |
(0.60 |
) |
$ |
(3.98 |
) |
$ |
(1.13 |
) |
|||||
| Diluted net loss per ordinary share (***) |
$ |
(2.55 |
) |
$ |
(0.60 |
) |
$ |
(3.98 |
) |
$ |
(1.13 |
) |
|||||
| Weighted average number of ordinary shares used in computing basic loss per ordinary share |
|
34,572,774 |
|
|
34,547,633 |
|
|
34,569,215 |
|
|
34,539,378 |
|
|||||
| Weighted average number of ordinary shares used in computing diluted loss per ordinary share |
|
34,572,774 |
|
|
34,547,633 |
|
|
34,569,215 |
|
|
34,539,378 |
|
|||||
| (*) Related to closed plants. | |||||||||||||||||
| (**) Impairment related to long lived assets. | |||||||||||||||||
| (***) The numerator for the calculation of net loss per share for the three and twelve months ended |
|||||||||||||||||
|
|
|||||||||
|
Twelve months ended |
|||||||||
|
|
2025 |
2024 |
|||||||
| (Audited) | |||||||||
| Cash flows from operating activities: |
|
|
|||||||
|
|
|
||||||||
| Net loss |
$ |
(137,759 |
) |
$ |
(42,976 |
) |
|||
| Adjustments required to reconcile net loss to net cash provided by operating activities: |
|
|
|||||||
| Depreciation and amortization |
|
14,199 |
|
|
17,134 |
|
|||
| Share-based compensation expense |
|
1,200 |
|
|
2,044 |
|
|||
| Accrued severance pay, net |
|
189 |
|
|
392 |
|
|||
| Changes in deferred tax, net |
|
(961 |
) |
|
(621 |
) |
|||
| Capital loss |
|
149 |
|
|
980 |
|
|||
| Legal settlements and loss contingencies, net |
|
25,555 |
|
|
18,748 |
|
|||
| Decrease in trade receivables |
|
88 |
|
|
6,857 |
|
|||
| Decrease in other accounts receivable and prepaid expenses |
|
10,966 |
|
|
20,128 |
|
|||
| Decrease in inventories |
|
21,099 |
|
|
8,952 |
|
|||
| Decrease in trade payables |
|
(15,342 |
) |
|
(579 |
) |
|||
| Increase in warranty provision |
|
170 |
|
|
7,242 |
|
|||
| Changes in right of use assets |
|
14,213 |
|
|
3,371 |
|
|||
| Changes in lease liabilities |
|
(1,959 |
) |
|
(5,006 |
) |
|||
| Contingent consideration related to acquisitions |
|
- |
|
|
(53 |
) |
|||
| Decrease in accrued expenses and other liabilities including related parties |
|
(18,589 |
) |
|
(5,746 |
) |
|||
| Restructuring expenses and Impairment related to long lived assets |
|
48,753 |
|
|
1,007 |
|
|||
| Net cash (used in) provided by operating activities |
|
(38,029 |
) |
|
31,874 |
|
|||
|
|
|
||||||||
|
|
|
||||||||
| Cash flows from investing activities: |
|
|
|||||||
|
|
|
||||||||
| Net cash paid for acquisitions |
|
- |
|
|
(1,556 |
) |
|||
| Purchase of property, plant and equipment |
|
(9,036 |
) |
|
(10,421 |
) |
|||
| Proceeds from sale of property, plant and equipment |
|
3,735 |
|
|
67 |
|
|||
| Decrease (increase) in long term deposits |
|
(243 |
) |
|
51 |
|
|||
| Net cash used in investing activities |
|
(5,544 |
) |
|
(11,859 |
) |
|||
|
|
|
||||||||
|
|
|
||||||||
| Cash flows from financing activities: |
|
|
|||||||
|
|
|
||||||||
| Changes in short-term bank credits and long-term loans, including related parties |
|
(1,960 |
) |
|
(2,545 |
) |
|||
| Payments related to transactions with non-controlling interest |
|
(1,920 |
) |
|
- |
|
|||
| Contingent consideration related to acquisition |
|
- |
|
|
(500 |
) |
|||
| Net cash used in financing activities |
|
(3,880 |
) |
|
(3,045 |
) |
|||
|
|
|
||||||||
|
|
|
||||||||
| Effect of exchange rate differences on cash and cash equivalents |
|
1,037 |
|
|
(1,757 |
) |
|||
|
|
|
||||||||
| Increase (decrease) in cash and cash equivalents and short-term bank deposits |
|
(46,416 |
) |
|
15,213 |
|
|||
| Cash and cash equivalents and short-term bank deposits at beginning of the period |
|
106,336 |
|
|
91,123 |
|
|||
|
|
|
||||||||
| Cash and cash equivalents and short-term bank deposits at end of the period |
$ |
59,920 |
$ |
106,336 |
|||||
|
|
|
||||||||
| Non - cash investing: |
|
|
|||||||
| Changes in trade payables balances related to purchase of fixed assets |
|
(103 |
) |
|
106 |
|
|||
|
|
|||||||||||||||
|
Three months ended |
Twelve months |
||||||||||||||
|
|
2025 |
2024 |
2025 |
2024 |
|||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||
| Reconciliation of Gross profit to Adjusted Gross profit: | |||||||||||||||
| Gross profit |
$ |
14,608 |
|
$ |
18,988 |
$ |
73,280 |
$ |
96,675 |
||||||
| Share-based compensation expense (a) |
|
14 |
|
|
11 |
|
51 |
|
89 |
||||||
| Amortization of assets related to acquisitions |
|
66 |
|
|
70 |
|
270 |
|
282 |
||||||
| Residual operating expenses (income) related to closed plants after closing |
|
(31 |
) |
|
96 |
|
180 |
|
672 |
||||||
| Other non recurring items (b) |
|
2,311 |
|
|
141 |
|
1,855 |
|
182 |
||||||
| Adjusted Gross profit (Non-GAAP) |
$ |
16,968 |
|
$ |
19,306 |
$ |
75,636 |
$ |
97,900 |
||||||
|
(a) |
Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company. | ||||||||||||||
|
(b) |
Non recurring items related mainly to restructuring. | ||||||||||||||
|
|
||||||||||||||||||
|
Three months ended |
Twelve months |
|||||||||||||||||
|
|
2025 |
2024 |
2025 |
2024 |
||||||||||||||
| (Unaudited) | (Unaudited) | |||||||||||||||||
| Reconciliation of Net Loss to Adjusted EBITDA: | ||||||||||||||||||
| Net loss |
$ |
(87,936 |
) |
$ |
(24,455 |
) |
$ |
(137,759 |
) |
$ |
(42,976 |
) |
||||||
| Finance expenses, net |
|
2,747 |
|
|
2,860 |
|
|
7,766 |
|
|
9 |
|
||||||
| Taxes on income, net |
|
2,881 |
|
|
(1,361 |
) |
|
4,284 |
|
|
1,081 |
|
||||||
| Depreciation and amortization |
|
3,921 |
|
|
4,363 |
|
|
14,807 |
|
|
17,742 |
|
||||||
| Legal settlements and loss contingencies, net (a) |
|
16,177 |
|
|
1,629 |
|
|
25,555 |
|
|
7,242 |
|
||||||
| Contingent consideration adjustment related to acquisition |
|
- |
|
- |
|
- |
|
|
(53 |
) |
||||||||
| Share-based compensation expense (b) |
|
241 |
|
|
434 |
|
|
1,200 |
|
|
2,044 |
|
||||||
| Restructuring expense (c) |
|
3,050 |
|
|
7,827 |
|
|
3,096 |
|
|
1,005 |
|
||||||
| Impairment expenses (d) |
|
45,657 |
|
|
- |
|
|
45,657 |
|
|
- |
|
||||||
| Residual operating expenses related to closed plants after closing |
|
(193 |
) |
|
450 |
|
|
979 |
|
|
2,056 |
|
||||||
| Other non recurring items (e) |
|
2,311 |
|
|
284 |
|
|
1,855 |
|
|
325 |
|
||||||
| Adjusted EBITDA (Non-GAAP) |
$ |
(11,144 |
) |
$ |
(7,969 |
) |
$ |
(32,560 |
) |
$ |
(11,525 |
) |
||||||
|
(a) |
Consists primarily of legal settlements expenses and loss contingencies, net, related to product liability claims. |
|||||||||||||||||
|
(b) |
Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company. |
|||||||||||||||||
| (c) |
Related to closed plants activities. |
|||||||||||||||||
|
(d) |
Impairment related to long lived assets. |
|||||||||||||||||
|
(e) |
Non recurring items related mainly to restructuring. |
|||||||||||||||||
|
|
||||||||||||||||||
|
Three months ended |
Twelve months |
|||||||||||||||||
|
|
2025 |
2024 |
2025 |
2024 |
||||||||||||||
| (Unaudited) | (Unaudited) | |||||||||||||||||
| Reconciliation of net loss attributable to controlling interest to adjusted net loss attributable to controlling interest: | ||||||||||||||||||
| Net loss attributable to controlling interest |
$ |
(87,936 |
) |
$ |
(24,344 |
) |
$ |
(137,467 |
) |
$ |
(42,832 |
) |
||||||
| Legal settlements and loss contingencies, net (a) |
|
16,177 |
|
|
1,629 |
|
|
25,555 |
|
|
7,242 |
|
||||||
| Contingent consideration adjustment related to acquisition |
|
- |
|
- |
|
- |
|
|
(53 |
) |
||||||||
| Amortization of assets related to acquisitions, net of tax |
|
47 |
|
|
532 |
|
|
376 |
|
|
2,135 |
|
||||||
| Share-based compensation expense (b) |
|
241 |
|
|
434 |
|
|
1,200 |
|
|
2,044 |
|
||||||
| Non cash revaluation of lease liabilities (c) |
|
1,745 |
|
|
977 |
|
|
4,163 |
|
|
(2,039 |
) |
||||||
| Restructuring expenses (d) |
|
3,050 |
|
|
7,826 |
|
|
3,096 |
|
|
1,005 |
|
||||||
| Impairment expenses (e) |
|
45,657 |
|
|
- |
|
|
45,657 |
|
|
- |
|
||||||
| Residual operating expenses related to closed plants after closing |
|
(193 |
) |
|
450 |
|
|
979 |
|
|
2,056 |
|
||||||
| Other non recurring items (f) |
|
2,311 |
|
|
284 |
|
|
1,855 |
|
|
325 |
|
||||||
| Total adjustments |
|
69,035 |
|
|
12,132 |
|
|
82,881 |
|
|
12,715 |
|
||||||
| Less tax on non-tax adjustments (g) |
|
(2,259 |
) |
|
(240 |
) |
|
(2,660 |
) |
|
(328 |
) |
||||||
| Total adjustments after tax |
|
71,294 |
|
|
12,372 |
|
|
85,542 |
|
|
13,043 |
|
||||||
| Adjusted net loss attributable to controlling interest (Non-GAAP) |
$ |
(16,642 |
) |
$ |
(11,972 |
) |
$ |
(51,925 |
) |
$ |
(29,789 |
) |
||||||
| Adjusted loss per share (h) |
$ |
(0.48 |
) |
$ |
(0.35 |
) |
$ |
(1.50 |
) |
$ |
(0.86 |
) |
||||||
|
(a) |
Consists primarily of legal settlements expenses and loss contingencies, net, related to product liability claims |
|||||||||||||||||
|
(b) |
Share-based compensation includes expenses related to stock options and restricted stock units granted to employees and directors of the Company. |
|||||||||||||||||
|
(c) |
Exchange rate differences deriving from revaluation of lease contracts in accordance with FASB ASC 842. |
|||||||||||||||||
|
(d) |
Related to closed plants activities. |
|||||||||||||||||
|
(e) |
Related to closed plants activities. |
|||||||||||||||||
|
(f) |
Non recurring items related mainly to restructuring. |
|||||||||||||||||
|
(g) |
Tax adjustments for the three and twelve months ended |
|||||||||||||||||
|
(h) |
In calculating adjusted (Non-GAAP) loss per share, the diluted weighted average number of shares outstanding excludes the effects of share-based compensation expense in accordance with FASB ASC 718. |
|||||||||||||||||
|
|
||||||||||||||||||||||||
| Geographic breakdown of revenues by region | ||||||||||||||||||||||||
|
Three months ended |
Twelve months |
Three months ended |
Twelve months |
|||||||||||||||||||||
|
|
2025 |
2024 |
2025 |
2024 |
||||||||||||||||||||
| (Unaudited) | (Unaudited) | (Audited) |
YoY % change |
YoY % change CCB |
YoY % change |
YoY % change CCB |
||||||||||||||||||
|
|
$ |
41,420 |
$ |
46,353 |
$ |
186,885 |
$ |
219,559 |
-10.6 |
% |
-10.6 |
% |
-14.9 |
% |
-14.9 |
% |
||||||||
|
|
|
10,966 |
|
14,106 |
|
51,874 |
|
61,749 |
-22.3 |
% |
-22.3 |
% |
-16.0 |
% |
-14.1 |
% |
||||||||
|
|
|
656 |
|
244 |
|
1,461 |
|
1,392 |
168.9 |
% |
171.5 |
% |
5.0 |
% |
5.1 |
% |
||||||||
| America's |
|
53,042 |
|
60,703 |
|
240,220 |
|
282,700 |
-12.6 |
% |
-12.6 |
% |
-15.0 |
% |
-14.6 |
% |
||||||||
|
|
|
18,515 |
|
16,870 |
|
67,480 |
|
75,388 |
9.8 |
% |
9.8 |
% |
-10.5 |
% |
-8.5 |
% |
||||||||
|
|
|
5,347 |
|
4,317 |
|
18,224 |
|
20,577 |
23.9 |
% |
25.1 |
% |
-11.4 |
% |
-10.4 |
% |
||||||||
| APAC |
|
23,862 |
|
21,187 |
|
85,704 |
|
95,965 |
12.6 |
% |
12.9 |
% |
-10.7 |
% |
-8.9 |
% |
||||||||
| EMEA |
|
12,105 |
|
11,858 |
|
51,952 |
|
47,121 |
2.1 |
% |
-5.3 |
% |
10.3 |
% |
6.2 |
% |
||||||||
|
|
|
5,426 |
|
4,115 |
|
19,352 |
|
17,435 |
31.9 |
% |
17.2 |
% |
11.0 |
% |
3.3 |
% |
||||||||
| Total Revenues |
$ |
94,435 |
$ |
97,863 |
$ |
397,228 |
$ |
443,221 |
-3.5 |
% |
-5.0 |
% |
-10.4 |
% |
-10.5 |
% |
||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20260304183136/en/
Investor Relations:
CSTE@icrinc.com
+1 (646) 200-8870
Source: